Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 69

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors

Weigelt, Karin, Carvalho, Livia A., Drexhage, Roos C., Wijkhuijs, Annemarie, Wit, Harm de, van Beveren, Nico J.M., Birkenhäger, Tom K., Bergink, Veerle, Drexhage, Hemmo A. · 2011 · Brain, Behavior, and Immunity

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2011.03.006

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Andreasen, 1992, The Comprehensive Assesment of Symptoms and History (CASH). An instrument for assesing diagnosis and psychopathology, Arch. Gen. Psychiatry, 49, 615, 10.1001/archpsyc.1992.01820080023004 · DOI · Paper page
  2. Anderson, 2000, Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells, J. Immunol., 164, 1855, 10.4049/jimmunol.164.4.1855 · DOI · Paper page
  3. Bamias, 2003, Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease, J. Immunol., 171, 4868, 10.4049/jimmunol.171.9.4868 · DOI · Paper page
  4. Beillard, 2003, Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program, Leukemia, 17, 2474, 10.1038/sj.leu.2403136 · DOI · Paper page
  5. Bessis, 2007, Microglial control of neuronal death and synaptic properties, Glia, 55, 233, 10.1002/glia.20459 · DOI · Paper page
  6. Beyan, 2010, Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins, Diabetes, 59, 1751, 10.2337/db09-1433 · DOI
  7. Bouchon, 2001, TREM-1 amplifies inflammation and is a crucial mediator of septic shock, Nature, 410, 1103, 10.1038/35074114 · DOI · Paper page
  8. Carter, 2007, Early growth response transcriptional regulators are dispensable for macrophage differentiation, J. Immunol., 178, 3038, 10.4049/jimmunol.178.5.3038 · DOI
  9. Dantzer, 2001, Cytokine-induced sickness behavior: mechanisms and implications, Ann. NY Acad. Sci., 933, 222, 10.1111/j.1749-6632.2001.tb05827.x · DOI · Paper page
  10. del Fresno, 2008, Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism, PLoS One, 3, e2667, 10.1371/journal.pone.0002667 · DOI
  11. Doorduin, 2009, Neuroinflammation in schizophrenia-related psychosis: a PET study, J. Nucl. Med., 50, 1801, 10.2967/jnumed.109.066647 · DOI · Paper page
  12. Dower, 2008, Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide, J. Immunol., 180, 3520, 10.4049/jimmunol.180.5.3520 · DOI · Paper page
  13. Drexhage, R.C., van der Heul-Nieuwenhuijsen, L., Padmos, R.C., van Beveren, N., Cohen, D., Versnel, M.A., Nolen, W.A., Drexhage, H.A., 2010. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int. J. Neuropsychopharmacol./Official Sci. J. Collegium Internationale Neuropsychopharmacologicum (CINP), 1–13. · DOI · Paper page
  14. Dunn, 2005, Cytokines as mediators of depression: what can we learn from animal studies?, Neurosci. Biobehav. Rev., 29, 891, 10.1016/j.neubiorev.2005.03.023 · DOI · Paper page
  15. Eisenberger, 2010, Inflammation and social experience.: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood, Brain Behav. Immun., 24, 558, 10.1016/j.bbi.2009.12.009 · DOI · Paper page
  16. Eldredge, 2008, Abnormal sympathetic nervous system development and physiological dysautonomia in Egr3-deficient mice, Development, 135, 2949, 10.1242/dev.023960 · DOI
  17. Eramaa, 1992, Activin A/erythroid differentiation factor is induced during human monocyte activation, J. Exp. Med., 176, 1449, 10.1084/jem.176.5.1449 · DOI
  18. First MB, S.R., Gibbon, M., Williams, J.B.W. (Eds.), 1999. Structured Clinical Interview for DSM IV Axis I Disorders, Patient Edition (Nederlandse Versie). Swets and Zeitlinger, BV: Lisse, Nederland.
  19. Gallant, 2006, ETS transcription factors and regulation of immunity, Arch. Immunol. Ther. Exp. (Warsz), 54, 149, 10.1007/s00005-006-0017-z · DOI · Paper page
  20. Gallitano-Mendel, 2007, The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty, Neuroscience, 148, 633, 10.1016/j.neuroscience.2007.05.050 · DOI
  21. Gallitano-Mendel, 2008, Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects, Neuropsychopharmacology, 33, 1266, 10.1038/sj.npp.1301505 · DOI
  22. Ghisletti, 2010, Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages, Immunity, 32, 317, 10.1016/j.immuni.2010.02.008 · DOI · Paper page
  23. Gibot, 2004, A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis, J. Exp. Med., 200, 1419, 10.1084/jem.20040708 · DOI · Paper page
  24. Gilchrist, 2006, Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4, Nature, 441, 173, 10.1038/nature04768 · DOI · Paper page
  25. Gomez-Pina, 2007, Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes, J. Immunol., 179, 4065, 10.4049/jimmunol.179.6.4065 · DOI · Paper page
  26. Greenberg, 2000, Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes, Cancer, 89, 356, 10.1002/1097-0142(20000715)89:2<356::AID-CNCR21>3.0.CO;2-Z · doi:10.1002/1097-0142(20000715)89:2<356::aid-cncr21>3.0.co;2-z
  27. Gribi, 2001, Expression of activin A in inflammatory arthropathies, Mol. Cell. Endocrinol., 180, 163, 10.1016/S0303-7207(01)00517-2 · doi:10.1016/s0303-7207(01)00517-2
  28. Grinberg, 2004, Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells, Mol. Cell Biol., 24, 4294, 10.1128/MCB.24.10.4294-4308.2004 · DOI · Paper page
  29. Guo, 2010, A novel microRNA and transcription factor mediated regulatory network in schizophrenia, BMC Sys. Bio., 4, 10, 10.1186/1752-0509-4-10 · DOI · Paper page
  30. Hamerman, J.A., Lanier, L.L., 2006. Inhibition of immune responses by ITAM-bearing receptors. Sci. STKE 2006, re1. · DOI
  31. Hubner, 1997, Activin A: a novel player and inflammatory marker in inflammatory bowel disease?, Lab. Invest., 77, 311
  32. Innamorato, 2008, The transcription factor Nrf2 is a therapeutic target against brain inflammation, J. Immunol., 181, 680, 10.4049/jimmunol.181.1.680 · DOI · Paper page
  33. Innamorato, 2009, Role of microglial redox balance in modulation of neuroinflammation, Curr. Opin. Neurol., 22, 308, 10.1097/WCO.0b013e32832a3225 · DOI
  34. Johnson, 2010, The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis, Toxicol. Sci., 114, 237, 10.1093/toxsci/kfp274 · DOI · Paper page
  35. Klesney-Tait, 2007, Uncovering the TREM-1-TLR connection, Am. J. Physiol. Lung Cell Mol. Physiol., 293, L1374, 10.1152/ajplung.00415.2007 · DOI
  36. Knapp, 2004, Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia, J. Immunol., 173, 7131, 10.4049/jimmunol.173.12.7131 · DOI
  37. Knijff, 2006, A relative resistance of T cells to dexamethasone in bipolar disorder, Bipolar Disord., 8, 740, 10.1111/j.1399-5618.2006.00359.x · DOI
  38. Kong, 2010, NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice, J. Immunol., 185, 569, 10.4049/jimmunol.0902315 · DOI · Paper page
  39. Lloberas, 1999, The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages, Immunol. Today, 20, 184, 10.1016/S0167-5699(99)01442-5 · DOI · Paper page
  40. Lyons, 2007, Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification, BMC Genomics, 8, 64, 10.1186/1471-2164-8-64 · DOI
  41. Motohashi, 1997, The world according to Maf, Nucleic Acids Res., 25, 2953, 10.1093/nar/25.15.2953 · DOI · Paper page
  42. Motohashi, 2004, Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway, Proc. Nat. Acad. Sci. USA, 101, 6379, 10.1073/pnas.0305902101 · DOI · Paper page
  43. Myers, 2009, Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells, PLoS Pathog., 5, e1000659, 10.1371/journal.ppat.1000659 · DOI
  44. Narayan, 2008, Molecular profiles of schizophrenia in the CNS at different stages of illness, Brain Res., 1239, 235, 10.1016/j.brainres.2008.08.023 · DOI · Paper page
  45. Post, 2001, The Stanley Foundation Bipolar Network. I. Rationale and methods, Br. J. Psychiatry, 41, s169, 10.1192/bjp.178.41.s169 · DOI
  46. Potvin, 2008, Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review, Biol. Psychiatry, 63, 801, 10.1016/j.biopsych.2007.09.024 · DOI · Paper page
  47. Rojo, 2010, Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson’s disease, Glia, 58, 588, 10.1002/glia.20947 · DOI · Paper page
  48. Schuld, 2004, [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness] Zytokinnetzwerke bei Patienten mit Schizophrenie und ihre Bedeutung fur die Pathophysiologie der Erkrankung, Nervenarzt, 75, 215, 10.1007/s00115-003-1599-x · DOI
  49. Sharif, 2007, Transcriptional profiling of the LPS induced NF-kappaB response in macrophages, BMC Immunol., 8, 1, 10.1186/1471-2172-8-1 · DOI · Paper page
  50. Smith, 1992, A comprehensive macrophage-T-lymphocyte theory of schizophrenia, Med. Hypotheses, 39, 248, 10.1016/0306-9877(92)90117-U · DOI
  51. Smith, 1995, The macrophage-T-lymphocyte theory of schizophrenia: additional evidence, Med. Hypotheses, 45, 135, 10.1016/0306-9877(95)90062-4 · DOI · Paper page
  52. Staal, 2004, Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion, J. Immunol., 172, 1099, 10.4049/jimmunol.172.2.1099 · DOI
  53. Svaren, 1998, Novel mutants of NAB corepressors enhance activation by Egr transactivators, EMBO J., 17, 6010, 10.1093/emboj/17.20.6010 · DOI
  54. Tessarz, 2008, The TREM-1/DAP12 pathway, Immunol. Lett., 116, 111, 10.1016/j.imlet.2007.11.021 · DOI · Paper page
  55. Tourtellotte, 2000, Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis, Mol. Cell Biol., 20, 5261, 10.1128/MCB.20.14.5261-5268.2000 · DOI
  56. Turnbull, 2007, Activating and inhibitory functions of DAP12, Nat. Rev. Immunol., 7, 155, 10.1038/nri2014 · DOI · Paper page
  57. van der Heul-Nieuwenhuijsen, 2010, An inflammatory gene-expression fingerprint in monocytes of autoimmune thyroid disease patients, J. Clin. Endocrinol. Metab., 95, 1962, 10.1210/jc.2009-1455 · DOI
  58. Weigelt, 2007, Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation, J. Leukoc. Biol., 82, 1564, 10.1189/jlb.0707447 · DOI · Paper page
  59. Weigelt, 2009, Transcriptomic profiling identifies a PU.1 regulatory network in macrophages, Biochem. Biophys. Res. Commun., 380, 308, 10.1016/j.bbrc.2009.01.067 · DOI · Paper page
  60. Yamada, 2007, Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia, Proc. Nat. Acad. Sci. USA, 104, 2815, 10.1073/pnas.0610765104 · DOI · Paper page
  61. Ye, 2006, The novel human gene MIP functions as a co-activator of hMafF, Arch. Biochem. Biophys., 449, 87, 10.1016/j.abb.2006.02.011 · doi:10.1016/j.abb.2006.02.011
  62. Yu, 1998, Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies, Clin. Exp. Immunol., 112, 126, 10.1046/j.1365-2249.1998.00522.x · DOI
  63. Zeng, 2007, TREM-1 expression in macrophages is regulated at transcriptional level by NF-kappaB and PU.1, Eur. J. Immunol., 37, 2300, 10.1002/eji.200737270 · DOI

Cited by

See all 69

Metadata

Authors
Weigelt, K., Carvalho, L. A., Drexhage, R. C., Wijkhuijs, A., Wit, H. D., van Beveren, N. J. M., Birkenhäger, T. K., Bergink, V., & Drexhage, H. A.
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2011-08
Volume
25
Issue
6
Pages
1162-1169
ISSN
0889-1591
Cited by
69
References
19
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Netherlands Organisation for Health Research and Development
  • European Union
  • Stanley Medical Research Institute
  • Dutch Diabetic Foundation
  • JDRF

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.